Qube Research & Technologies (QRT)’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.17M Buy
+880,387
New +$9.83M 0.01% 1337
2026
Q1
Sell
-72,690
Closed -$724K 3493
2025
Q4
$724K Buy
+72,690
New +$694K ﹤0.01% 2688
2024
Q1
Sell
-29,704
Closed -$217K 4424
2023
Q4
$217K Buy
+29,704
New +$234K ﹤0.01% 2748
2023
Q1
Sell
-19,055
Closed -$366K 2495
2022
Q4
$366K Sell
19,055
-22,589
-54% -$478K ﹤0.01% 1589
2022
Q3
$782K Buy
+41,644
New +$856K ﹤0.01% 1287
2022
Q2
Sell
-54,386
Closed -$872K 2442
2022
Q1
$872K Buy
+54,386
New +$978K 0.01% 1238

Other funds holding AHCO

Qube Research & Technologies (QRT)'s AHCO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) opened a new position in AdaptHealth (AHCO) in Q2 2026: 880,387 shares worth $9.17M. The stake represents 0.01% of the portfolio and ranks #1337 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in AHCO as recently as Q4 2025.

Qube Research & Technologies (QRT) first reported a position in AHCO in Q1 2022 and has held it in 6 quarters since. 238 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Qube Research & Technologies (QRT) held 880,387 shares of AdaptHealth worth $9.17M as of Q2 2026.
  • AdaptHealth was a new Qube Research & Technologies (QRT) position in Q2 2026.
  • AdaptHealth made up 0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1337 holding.
  • Qube Research & Technologies (QRT) first reported a position in AdaptHealth in Q1 2022 and has held it in 6 quarters since.
  • 238 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.